ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 117 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 1.25 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $1,315,000 | -87.0% | 128,300 | -79.0% | 0.18% | -83.4% |
| Q3 2018 | $10,150,000 | -38.2% | 609,612 | -41.3% | 1.08% | -41.3% |
| Q2 2018 | $16,415,000 | +49.7% | 1,038,900 | +20.3% | 1.84% | +52.5% |
| Q1 2018 | $10,968,000 | -26.1% | 863,600 | +21.1% | 1.20% | -30.5% |
| Q1 2017 | $14,833,000 | +6.5% | 713,119 | +6.5% | 1.73% | +12.3% |
| Q4 2016 | $13,923,000 | -20.9% | 669,351 | +24.6% | 1.54% | -10.8% |
| Q3 2016 | $17,601,000 | +34.2% | 537,121 | +2.3% | 1.73% | +27.6% |
| Q2 2016 | $13,115,000 | -58.5% | 525,221 | -59.3% | 1.35% | -11.4% |
| Q1 2016 | $31,620,000 | +2.4% | 1,291,153 | +38.1% | 1.53% | +16.1% |
| Q4 2015 | $30,881,000 | +23.6% | 934,951 | +22.6% | 1.32% | +15.0% |
| Q3 2015 | $24,985,000 | -30.9% | 762,682 | +11.7% | 1.14% | -24.1% |
| Q2 2015 | $36,165,000 | +16.8% | 682,736 | -36.3% | 1.51% | +28.3% |
| Q1 2015 | $30,951,000 | +920.1% | 1,072,437 | +928.2% | 1.18% | +764.0% |
| Q4 2014 | $3,034,000 | +168.0% | 104,300 | +16.8% | 0.14% | +183.3% |
| Q3 2014 | $1,132,000 | +39.2% | 89,300 | +120.4% | 0.05% | +41.2% |
| Q2 2014 | $813,000 | – | 40,525 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,203 | $36,042,000 | 9.93% |
| Foresite Capital Management II, LLC | 1,043,832 | $12,787,000 | 5.18% |
| Redmile Group, LLC | 6,476,766 | $79,340,000 | 3.91% |
| DAFNA Capital Management LLC | 346,013 | $4,239,000 | 2.63% |
| Cormorant Asset Management, LP | 900,000 | $11,025,000 | 1.95% |
| SENZAR ASSET MANAGEMENT, LLC | 641,170 | $7,854,000 | 1.92% |
| Asymmetry Capital Management, L.P. | 105,228 | $1,289,000 | 1.50% |
| New Leaf Venture Partners, L.L.C. | 171,364 | $2,099,000 | 0.97% |
| EMERALD ADVISERS, LLC | 1,578,477 | $19,336,000 | 0.79% |
| BB BIOTECH AG | 2,266,008 | $27,759,000 | 0.77% |